CliffBio
small molecule

GENTAMICIN SULFATE

GENTAMICIN SULFATE

Loss of exclusivity—loss of exclusivity
CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand nameGENTAMICIN SULFATE
Active ingredientGENTAMICIN SULFATE
StrengthEQ 0.3% BASE
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalNovember 1985
Marketing statusDISCN

More from Alcon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

GENTAMICIN SULFATE patent cliff — loss of exclusivity — | CliffBio